Page last updated: 2024-08-25

drospirenone and Bone Diseases, Metabolic

drospirenone has been researched along with Bone Diseases, Metabolic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cho, S; Choi, YS; Jeon, YE; Lee, BS; Lim, KJ; Seo, SK; Yang, HI	1

Trials

1 trial(s) available for drospirenone and Bone Diseases, Metabolic

Article	Year
Changes in serum levels of cartilage oligomeric matrix protein after estrogen and alendronate therapy in postmenopausal women. Gynecologic and obstetric investigation, 2012, Volume: 74, Issue:2 Topics: Aged; Alendronate; Androstenes; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Cartilage; Cartilage Oligomeric Matrix Protein; Estradiol; Extracellular Matrix Proteins; Female; Glycoproteins; Humans; Matrilin Proteins; Middle Aged; Mineralocorticoid Receptor Antagonists; Osteoarthritis; Osteocalcin; Osteoporosis, Postmenopausal; Postmenopause	2012

Article

Year

Changes in serum levels of cartilage oligomeric matrix protein after estrogen and alendronate therapy in postmenopausal women.

Gynecologic and obstetric investigation, 2012, Volume: 74, Issue:2

Topics: Aged; Alendronate; Androstenes; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Cartilage; Cartilage Oligomeric Matrix Protein; Estradiol; Extracellular Matrix Proteins; Female; Glycoproteins; Humans; Matrilin Proteins; Middle Aged; Mineralocorticoid Receptor Antagonists; Osteoarthritis; Osteocalcin; Osteoporosis, Postmenopausal; Postmenopause

2012